Closing Bell: Goldies glitter as ASX grinds out a flattish Friday
ASX Small Caps Weekly Form Guide
Gold Digger: Momentum is against gold. Can it be clawed back?
Resources Top 5: Nanadie breakthrough powers Solstice as BOA grows copper ambitions
Lunch Wrap: Tech weighs on ASX, 4DMedical tumbles despite TGA win
Ten Bagger: Shift to ‘value over volume’ supporting critical minerals prices
Rise and Shine: Everything you need to know before the ASX opens
Tungsten Mining charges towards production as the West scrambles for new tungsten supply
Non-banks are taking the wheel in vehicle finance
Morning Feed: What’s cooking on the ASX?
Contributors
Our Resident Experts
Mining
Gold Digger: Momentum is against gold. Can it be clawed back?
Ten Bagger: Shift to ‘value over volume’ supporting critical minerals prices
Tungsten Mining charges towards production as the West scrambles for new tungsten supply
Resources Top 5: Renascor tips Flat Hill copper system; Li-S sells first lithium foil
Creating a Legacy: How juniors are using AI in the hunt for new deposits
Featured in Mining
Tech
Unicorns Podcast: How Ordermentum is building the future of hospitality
Elon Musk and SpaceX mark a game-changer for share investing
Top deal-maker slams Labor’s ‘joke’ innovation tax plan
The defence boom is creating a new breed of ASX small caps
Microsoft’s AI is now helping BHP mine copper
Featured in Tech
Health & Biotech
Health Check: Avecho is awake to the possibilities after interim phase III insomnia trial win
Biocurious: Silence is golden as Optiscan targets the US veterinarian market
Dr Boreham’s Crucible: EBR gets Wise to a US opportunity worth billions
Health Kick Podcast: Supermarket success brings Calmer Co to flavour country
Health Check: Woundcare house tackles overlooked women’s cancer sector
Featured in Health & Biotech
Experts
New CGT rules create complex two-step tax system for investors
Elon Musk and SpaceX mark a game-changer for share investing
Health Check: Woundcare house tackles overlooked women’s cancer sector
Criterion: How to avoid the ‘crowded trade’ in a top-heavy market
Dr Boreham’s Crucible: Opthea seeks a second act with rare lung disease program
10 tax and super changes you need to know
Tighter supply, stronger demand lift outlook for PGMs
